Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p
- PMID: 32943997
- PMCID: PMC7488500
- DOI: 10.1186/s12935-020-01538-8
Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p
Abstract
Background: We aimed to explore the role of long noncoding RNA urothelial carcinoma-associated 1 (lncRNA UCA1) and its underlying mechanism in the radioresistance of prostate cancer (PCa).
Methods: QRT-PCR was conducted to measure the expression of UCA1, microRNA-331-3p (miR-331-3p) and eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in PCa tissues and cells. The relative protein level was determined by western blot assay. Cell proliferation and apoptosis were detected by MTT, colony formation assay, and flow cytometry, respectively. The target interaction between miR-331-3p and UCA1 or EIF4G1 was predicted through bioinformatics analysis, and verified by dual-luciferase reporter gene assay system.
Results: The high levels of UCA1 and EIF4G1 as well as the low level of miR-331-3p were observed in PCa tissues and cell lines. UCA1 and EIF4G1 expression were significantly upregulated by Gy radiation treatement. UCA1 or EIF4G1 knockdown repressed cell growth and enhanced cell apoptosis in 22RV1 and DU145 cells under radiation. Moreover, overexpression of EIF4G1 abolished UCA1 knockdown-induced effect on 6 Gy irradiated PCa cells. UCA1 sponged miR-331-3p to regulate EIF4G1 expression.
Conclusions: LncRNA UCA1 deletion suppressed the radioresistance to PCa by suppressing EIF4G1 expression via miR-331-3p. UCA1 acted as a potential regulator of radioresistance of PCa, providing a promising therapeutic target for PCa.
Keywords: EIF4G1; Prostate cancer; Radioresistance; UCA1; miR-331-3p.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures






Similar articles
-
SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.J Cell Biochem. 2019 Apr;120(4):6671-6682. doi: 10.1002/jcb.27963. Epub 2018 Oct 28. J Cell Biochem. 2019. PMID: 30368875
-
Circ-ZNF609 Accelerates the Radioresistance of Prostate Cancer Cells by Promoting the Glycolytic Metabolism Through miR-501-3p/HK2 Axis.Cancer Manag Res. 2020 Aug 20;12:7487-7499. doi: 10.2147/CMAR.S257441. eCollection 2020. Cancer Manag Res. 2020. PMID: 32943916 Free PMC article.
-
lncRNA UCA1 Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells Through miR-23b-3p/ZNF281 Axis.Onco Targets Ther. 2020 Jul 31;13:7571-7583. doi: 10.2147/OTT.S258727. eCollection 2020. Onco Targets Ther. 2020. PMID: 32801774 Free PMC article.
-
Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression By Modulating miR-124-3p/ITGB1 Axis.Onco Targets Ther. 2019 Oct 11;12:8455-8466. doi: 10.2147/OTT.S215819. eCollection 2019. Onco Targets Ther. 2019. Retraction in: Onco Targets Ther. 2022 Jan 25;15:117-118. doi: 10.2147/OTT.S358906. PMID: 31632090 Free PMC article. Retracted.
-
Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9238-9250. doi: 10.26355/eurrev_201911_19416. Eur Rev Med Pharmacol Sci. 2019. PMID: 31773675
Cited by
-
The Role of LncRNAs in Translation.Noncoding RNA. 2021 Feb 20;7(1):16. doi: 10.3390/ncrna7010016. Noncoding RNA. 2021. PMID: 33672592 Free PMC article. Review.
-
Knockdown of UCA1 restrains cell proliferation and metastasis of diffuse large B-cell lymphoma by counteracting miR-331-3p expression.Oncol Lett. 2021 Jan;21(1):39. doi: 10.3892/ol.2020.12300. Epub 2020 Nov 13. Oncol Lett. 2021. PMID: 33262831 Free PMC article.
-
Long non-coding RNA in prostate cancer.Am J Clin Exp Urol. 2022 Jun 15;10(3):170-179. eCollection 2022. Am J Clin Exp Urol. 2022. PMID: 35874287 Free PMC article. Review.
-
Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology.J Pers Med. 2022 Sep 29;12(10):1605. doi: 10.3390/jpm12101605. J Pers Med. 2022. PMID: 36294743 Free PMC article. Review.
-
Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis.Front Pharmacol. 2025 Jan 7;15:1483186. doi: 10.3389/fphar.2024.1483186. eCollection 2024. Front Pharmacol. 2025. PMID: 39845793 Free PMC article.
References
-
- Litwin MS, et al. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317(24):2532–42. - PubMed
-
- Evans-Axelsson S, et al. Radioimmunotherapy for prostate cancer–current status and future possibilities. Semin Nucl Med. 2016;46(2):165–79. - PubMed
-
- Li S, et al. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Biomed Pharmacother. 2018;104:451–7. - PubMed
-
- Zhang PF, et al. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma. J Cell Physiol. 2019;234(3):2788–94. - PubMed
LinkOut - more resources
Full Text Sources